Insights

Funding Leadership As a leading global funder of neuroendocrine cancer research with over 37.6 million dollars invested since 2005, NETRF demonstrates a strong commitment to advancing research, making it a prime target for companies offering research tools, pharmaceuticals, or funding services.

Research Collaboration NETRF actively partners with international organizations such as INCA and collaborates with prominent entities like AACR, indicating that they value strategic alliances, which presents opportunities for partnership or joint ventures in research infrastructure and collaborative programs.

Technological Adoption Utilizing a range of digital tools including Google Ads, Facebook Pixel, and MySQL, NETRF is engaged in modern, data-driven outreach and research processes, suggesting potential for tech vendors offering digital marketing, data analytics, or research software solutions.

Community Engagement Initiatives like the Everlasting Impact Tribute and the launch of the NETWise Podcast highlight their focus on community and stakeholder engagement, opening doors for organizations providing participant engagement platforms, memorial services, or content marketing solutions.

Research Expansion Recent efforts such as developing mouse models for testing lead candidates indicate ongoing investments in expanding preclinical research capabilities, presenting sales opportunities in laboratory equipment, animal model services, or biotech research supplies.

Similar companies to Neuroendocrine Tumor Research Foundation

Neuroendocrine Tumor Research Foundation Tech Stack

Neuroendocrine Tumor Research Foundation uses 8 technology products and services including Google Ads, Facebook Pixel, CookieYes, and more. Explore Neuroendocrine Tumor Research Foundation's tech stack below.

  • Google Ads
    Advertising
  • Facebook Pixel
    Analytics
  • CookieYes
    Cookie Compliance
  • MySQL
    Database
  • JSON-LD
    Javascript Frameworks
  • Slick
    Javascript Libraries
  • Slider Revolution
    Miscellaneous
  • Smush
    Web Tools And Plugins

Neuroendocrine Tumor Research Foundation's Email Address Formats

Neuroendocrine Tumor Research Foundation uses at least 1 format(s):
Neuroendocrine Tumor Research Foundation Email FormatsExamplePercentage
First.Last@netrf.orgJohn.Doe@netrf.org
100%

Frequently Asked Questions

Where is Neuroendocrine Tumor Research Foundation's headquarters located?

Minus sign iconPlus sign icon
Neuroendocrine Tumor Research Foundation's main headquarters is located at 100 Hancock Street Third Floor Quincy, Massachusetts United States. The company has employees across 1 continents, including North America.

What is Neuroendocrine Tumor Research Foundation's phone number?

Minus sign iconPlus sign icon
You can contact Neuroendocrine Tumor Research Foundation's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Neuroendocrine Tumor Research Foundation's official website and social media links?

Minus sign iconPlus sign icon
Neuroendocrine Tumor Research Foundation's official website is netrf.org and has social profiles on LinkedIn.

What is Neuroendocrine Tumor Research Foundation's SIC code NAICS code?

Minus sign iconPlus sign icon
Neuroendocrine Tumor Research Foundation's SIC code is 8399 - Social Services, Not Elsewhere Classified NAICS code is 5417 - Scientific Research and Development Services.

How many employees does Neuroendocrine Tumor Research Foundation have currently?

Minus sign iconPlus sign icon
As of April 2026, Neuroendocrine Tumor Research Foundation has approximately 11 employees across 1 continents, including North America. Key team members include Chief Executive Officer: E. G.Chief Development Officer: S. H.Director Of Digital Communications: A. G.. Explore Neuroendocrine Tumor Research Foundation's employee directory with LeadIQ.

What industry does Neuroendocrine Tumor Research Foundation belong to?

Minus sign iconPlus sign icon
Neuroendocrine Tumor Research Foundation operates in the Research Services industry.

What technology does Neuroendocrine Tumor Research Foundation use?

Minus sign iconPlus sign icon
Neuroendocrine Tumor Research Foundation's tech stack includes Google AdsFacebook PixelCookieYesMySQLJSON-LDSlickSlider RevolutionSmush.

What is Neuroendocrine Tumor Research Foundation's email format?

Minus sign iconPlus sign icon
Neuroendocrine Tumor Research Foundation's email format typically follows the pattern of First.Last@netrf.org. Find more Neuroendocrine Tumor Research Foundation email formats with LeadIQ.

When was Neuroendocrine Tumor Research Foundation founded?

Minus sign iconPlus sign icon
Neuroendocrine Tumor Research Foundation was founded in 2005.

Neuroendocrine Tumor Research Foundation

Research ServicesMassachusetts, United States11-50 Employees

The mission of the Neuroendocrine Tumor Research Foundation (NETRF) is to fund research to discover cures and more effective treatments for neuroendocrine cancer. NETRF is the leading global funder of neuroendocrine cancer research and has funded $37.6 million in large-scale, multi-year research grants to leading scientists worldwide since its inception in 2005.

Section iconCompany Overview

Headquarters
100 Hancock Street Third Floor Quincy, Massachusetts United States
Phone number
Website
netrf.org
SIC Code
8399 - Social Services, Not Elsewhere Classified
NAICS Code
5417 - Scientific Research and Development Services
Founded
2005
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    Neuroendocrine Tumor Research Foundation's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Neuroendocrine Tumor Research Foundation's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.